ロード中...
TRAIL: not just for tumors anymore?
Since the discovery of TNF-related apoptosis-inducing ligand (TRAIL) and its network of receptors, the majority of attention has focused on the clinical potential of manipulating this pathway in cancer therapy. However, the widespread expression of TRAIL under inflammatory conditions and the ability...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Rockefeller University Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3478931/ https://ncbi.nlm.nih.gov/pubmed/23091198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20122235 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|